Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies
暂无分享,去创建一个
G. Leuba | E. Hol | D. Mann | W. Kamphorst | P. Cras | R. Vos | H. Yamaguchi | C. van Broeckhoven | S. Kumar-Singh | J. Kros | R. D. de Vos | D. Fischer | B. Hobo | F. V. van Leeuwen | F. Leeuwen | P. Tijn | D. Mann | M. Maat‐Schieman | M. Sonnemans | A. Savioz | M. Maat-Schieman | P. van Tijn | C. V. Broeckhoven | H. Yamaguchi
[1] Bin Zhang,et al. Axonal transport defects: a common theme in neurodegenerative diseases , 2005, Acta Neuropathologica.
[2] G. Vattemi,et al. Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers , 2004, Neurology.
[3] R. Roos,et al. Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases. , 2004, Human molecular genetics.
[4] E. Hol,et al. Frame‐shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid β40 , 2004, Journal of neurochemistry.
[5] S. Lipton,et al. Molecular pathways to neurodegeneration , 2004, Nature Medicine.
[6] C. Almeida,et al. Oligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain , 2004, The Journal of Neuroscience.
[7] D. Wagner,et al. Proteasome inhibition arrests neurite outgrowth and causes “dying‐back” degeneration in primary culture , 2003, Journal of neuroscience research.
[8] W. Engel,et al. Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-&bgr;, misfolded proteins, predisposing genes, and aging , 2003, Current opinion in rheumatology.
[9] E. Hol,et al. Disease‐specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] E. Hol,et al. Frameshifted β-Amyloid Precursor Protein (APP+1) Is a Secretory Protein, and the Level of APP+1 in Cerebrospinal Fluid Is Linked to Alzheimer Pathology* , 2003, Journal of Biological Chemistry.
[11] Aaron Ciechanover,et al. The Ubiquitin Proteasome System in Neurodegenerative Diseases Sometimes the Chicken, Sometimes the Egg , 2003, Neuron.
[12] S. Kim,et al. Essential Role of E2-25K/Hip-2 in Mediating Amyloid-β Neurotoxicity , 2003 .
[13] G. Leuba,et al. Tau and neurofilaments in a family with frontotemporal dementia unlinked to chromosome 17q21–22 , 2003, Neurobiology of Disease.
[14] Cornelia M van Duijn,et al. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. , 2002, The American journal of pathology.
[15] E. Hol,et al. Molecular misreading of the ubiquitin B gene and hepatic mallory body formation. , 2002, Gastroenterology.
[16] E. Hol,et al. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation , 2002, The Journal of cell biology.
[17] Julio C. Echegoyen,et al. Inclusion body myositis-like phenotype induced by transgenic overexpression of βAPP in skeletal muscle , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Hol,et al. Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] T. Bayer,et al. Homodimerization of Amyloid Precursor Protein and Its Implication in the Amyloidogenic Pathway of Alzheimer's Disease* , 2001, The Journal of Biological Chemistry.
[20] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[21] M. Hersberger,et al. A dinucleotide deletion in amyloid precursor protein (APP) mRNA associated with sporadic Alzheimer's disease results in efficient secretion of truncated APP isoforms from neuroblastoma cell cultures , 2001, Journal of neurochemistry.
[22] G. Leuba,et al. Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease , 2000, Acta Neuropathologica.
[23] P. Davies,et al. Conformational change as one of the earliest alterations of tau in Alzheimer’s disease , 2000, Neurobiology of Aging.
[24] C. Pickart,et al. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] E. Hol,et al. Molecular misreading in non‐neuronal cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] H. Yamaguchi,et al. Age-related plaque morphology and C-terminal heterogeneity of amyloid β in Dutch-type hereditary cerebral hemorrhage with amyloidosis , 2000, Acta Neuropathologica.
[27] G. Leuba,et al. No Detected Mutations in the Genes for the Amyloid Precursor Protein and Presenilins 1 and 2 in a Swiss Early-Onset Alzheimer’s Disease Family with a Dominant Mode of Inheritance , 1999, Dementia and Geriatric Cognitive Disorders.
[28] E. Scherder,et al. Reduced neuronal activity and reactivation in Alzheimer's disease , 1998, European Neuropsychopharmacology.
[29] A. Hofman,et al. Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala→Gly mutation , 1998, Acta Neuropathologica.
[30] Y. Ihara,et al. Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques , 1998, Acta Neuropathologica.
[31] F. Grosveld,et al. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. , 1998, Science.
[32] S. Ochs,et al. The origin and nature of beading: A reversible transformation of the shape of nerve fibers , 1997, Progress in Neurobiology.
[33] T. Iwatsubo,et al. Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain , 1996, Neuroscience Letters.
[34] M. Cruts,et al. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. , 1995, Human molecular genetics.
[35] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[36] C. van Broeckhoven,et al. Early‐onset Alzheimer's disease in 2 large Belgian families , 1991, Neurology.
[37] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[38] J. Trojanowski,et al. Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.
[39] D. Ron,et al. Conformational disease , 2000, Nature Cell Biology.
[40] C. van Broeckhoven. Alzheimer's disease: identification of genes and genetic risk factors. , 1998, Progress in brain research.
[41] S. Hirai,et al. Immunohistochemical analysis of COOH-termini of amyloid beta protein (Aβ) using end-specific antisera for Aβ40 and Aβ42 in Alzheimer's disease and normal aging , 1995 .